Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis.
about
The Safety and Efficacy of Absorb Bioresorbable Vascular Scaffold: A Systematic ReviewSafety and efficacy of biodegradable drug-eluting vs. bare metal stents: a meta-analysis from randomized trialsNew-Generation Coronary Stents: Current Data and Future Directions.Percutaneous intervention versus coronary artery bypass graft surgery in left main coronary artery stenosis: a systematic review and meta-analysis.A prospective, multicenter, post marketing surveillance study to evaluate the safety and effectiveness of the Superia-Sirolimus Eluting Coronary Stent System (SSECSS) implanted during routine clinical practice in India.Improved treatment and prognosis after acute myocardial infarction in Estonia: cross-sectional study from a high risk countryUltrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE TrialRevascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft SurgeryThe Control of Drug Release and Vascular Endothelialization after Hyaluronic Acid-Coated Paclitaxel Multi-Layer Coating Stent Implantation in Porcine Coronary Restenosis Model.Meta-analysis of bioabsorbable versus durable polymer drug-eluting stents in 20,005 patients with coronary artery disease: an update.Choosing the right coronary stent in the modern era.Acute revascularization in ST-segment-elevation myocardial infarction.Coronary artery stents: advances in technology.PCI and CABG surgery in 2014: CABG surgery versus PCI in CAD--surgery strikes again!The everolimus-eluting Xience stent in small vessel disease: bench, clinical, and pathology view.Drug-eluting stents: the past, present, and future.Prevention of stent thrombosis: challenges and solutions.Causes, assessment, and treatment of stent thrombosis--intravascular imaging insights.Comparison of coronary artery bypass graft surgery and percutaneous coronary intervention in patients with diabetes.Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials.In situ Endothelialization: Bioengineering Considerations to Translation.Biodegradable polymer stents vs second generation drug eluting stents: A meta-analysis and systematic review of randomized controlled trials.Clinical implications of blood-material interaction and drug eluting stent polymers in review.Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.Adverse cardiovascular events associated with biodegradable polymer drug-eluting stents and durable polymer everolimus-eluting stents: A systematic review and meta-analysis of 10 randomized controlled trials.Comparison between imported versus domestic drug-eluting stents in China: A large single-center data.Four-year comparative effectiveness of bare-metal and everolimus-eluting stents in New York.Drug-eluting balloon versus bare-mental stent and drug-eluting stent for de novo coronary artery disease: A systematic review and meta-analysis of 14 randomized controlled trials.Bioresorbable Polymers and Stent Devices.Drug eluting stents: To evolve or dissolve?Bioresorbable Scaffolds for Coronary Artery Disease.Challenges with Evidence-Based Management of Stable Ischemic Heart Disease.Outcomes of Acute Myocardial Infarction Patients Implanted With Biodegradable Polymer Biolimus-Eluting Stents Versus New-Generation Durable Polymer Drug-Eluting Stents: A Retrospective Analysis.Variability in utilization of drug eluting stents in United States: Insights from nationwide inpatient sample.Cost-effectiveness of percutaneous coronary intervention with cobalt-chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta-analysis of randomized trials.Safety and efficacy profile of bioresorbable-polylactide-polymer-biolimus-A9-eluting stents versus durable-polymer-everolimus- and zotarolimus-eluting stents in patients with acute coronary syndrome.Comparison of the Absorbable Polymer Sirolimus-Eluting Stent (MiStent) to the Durable Polymer Everolimus-Eluting Stent (Xience) (from the DESSOLVE I/II and ISAR-TEST-4 Studies).Experimental and computational study of mechanical and transport properties of a polymer coating for drug-eluting stents.A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study.PCI or CABG for severe unprotected left main coronary artery disease: making sense of the NOBLE and EXCEL trials.
P2860
Q26782136-E8142C1C-417C-4348-86BA-43266D0CA4A7Q28539865-33D5C3C7-FB7A-4B3E-B385-B2068687810AQ31164040-A13B7F22-52B8-475C-876B-96368F0BB2D5Q33587407-EDA8BD06-E791-499A-BC14-0C939D1842FDQ35028726-CC73222A-AD89-4856-A7C0-4D72B6A35456Q35822223-F5EA82D6-0ED8-4173-8983-7445FB63DFD0Q37090890-A59F57FF-1925-4FCB-9C8C-F5D62F66843BQ37094848-2A081690-EE08-4228-8B03-091E094C7405Q37619061-59F8ACAF-81A3-4E62-A944-7CE604F470ABQ38183346-ADA68D72-4E5B-4840-92D4-E1C410853B58Q38194095-DD598356-C546-4AFE-9AC7-477B58F2F471Q38200569-2EC5EDCB-D4E3-4A34-8F6A-09E0DC7F4769Q38287152-E9E94ACC-F98B-490C-9D5F-A906634E31C6Q38307962-28CB75B5-B9E1-476F-8EAA-B908E69D877DQ38310049-01BA840F-FCF5-46F0-B6C1-FD729E858143Q38344198-40E6CFBC-71DA-4E6D-A201-73646C2B881AQ38346245-7A25C1B7-DFB6-4451-AD22-28DDC87437A1Q38381419-07161E3A-CC75-45C8-A37C-73FD2B4295DEQ38387683-1FB0C445-1FE8-4C50-AF44-447AFEB3FE38Q38398230-FD0A59C8-403C-4BF0-AA20-518C72D000E8Q38605831-488DCC03-6571-4501-8D93-ACBD8DE4FA50Q38620880-AD694B4F-4432-4783-863A-F43A9E5E9EC3Q38645043-E1CFFF3A-FD8E-4EA8-B98F-284487438244Q38652030-7627B49A-2159-4DD8-BEDB-55B4DA2C4C0EQ38682427-671A59E9-92B8-4739-8F13-298942B21DDBQ38697308-03F4B0F2-5509-46E6-AC58-E2A7FDA9C605Q38756844-CD3A9812-7CC3-4A89-98E9-B4D8F642EE4EQ38818530-438B0C87-2864-4E7D-8492-95326D7D94EFQ38919254-FFE95E73-ADAE-4F4F-B271-453D5860127CQ39008645-DFC88ABD-1D30-427F-8BD0-0909534E3DF7Q39097196-19B32BA0-BE0E-4CF4-9B5A-DED41D2461A7Q39129336-D0510716-9325-4C66-996F-5942CBED91F9Q39166453-EF4870E8-FDFE-427E-B063-4ADDA34C4D7CQ39335623-049C6137-AA5E-4750-BFBC-0C2A5A42E684Q39488157-7AD2265D-F7BD-4FD2-8BAC-0E958A6C1A75Q39632788-E337EF65-8024-45FF-B913-DCB7BE9EE590Q40112459-ED7FB04E-039C-4099-9F50-7D4F614618B3Q40273207-5F9A6771-4F8C-4BE5-B912-8A7C7553D666Q41347740-CCEE6ED1-4F8F-40E5-8DEB-26E2DE2758F5Q42340585-C9AF9EC1-BBB7-4509-BA5D-0BE1CDAFCFA2
P2860
Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Bare metal stents, durable pol ...... ment comparison meta-analysis.
@en
Bare metal stents, durable pol ...... ment comparison meta-analysis.
@nl
type
label
Bare metal stents, durable pol ...... ment comparison meta-analysis.
@en
Bare metal stents, durable pol ...... ment comparison meta-analysis.
@nl
prefLabel
Bare metal stents, durable pol ...... ment comparison meta-analysis.
@en
Bare metal stents, durable pol ...... ment comparison meta-analysis.
@nl
P2093
P2860
P356
P1433
P1476
Bare metal stents, durable pol ...... ment comparison meta-analysis.
@en
P2093
Bora Toklu
David P Faxon
Edward L Hannan
Frederick Feit
Mario Fusaro
Nicholas Amoroso
Sunil Kumar
P2860
P356
10.1136/BMJ.F6625
P407
P577
2013-11-08T00:00:00Z